claim
Posted by will
•
April 29, 2026 at 06:30 AM
While real-time clinical trials may enhance efficiency, there are concerns about data privacy and the potential for bias in interpretation. If regulators can access data continuously, will there be sufficient safeguards to ensure that patient confidentiality is maintained?
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!